Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2 - Wikidata - awgldk - TriplyDB

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

http://www.wikidata.org/entity/Q27681839

about

Recent advances in understanding hepatitis C Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: Case study of PI4KIIIβ with Rab11 Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization The impact of hepatitis C virus entry on viral tropism Fusion of Enveloped Viruses in Endosomes.Proteomic approaches to analyzing hepatitis C virus biology Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Isotope Labeling of Biomolecules: Structural Analysis of Viruses by HDX-MS.Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.The missing pieces of the HCV entry puzzle.The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.Protective immunity against hepatitis C: many shades of gray.Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Hepatitis C virus life cycle and lipid metabolism Applications of hydrogen/deuterium exchange MS from 2012 to 2014.Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development Role of Cysteines in Stabilizing the Randomized Receptor Binding Domains within Feline Leukemia Virus Envelope Proteins New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding

P2860

Q26766136-DFAD39BF-AA5E-49E0-9FEF-09C58499317E Q26772129-C516AD49-FF3F-4CBD-9B53-D3C9EA2450D0 Q26799141-14B139C3-90CF-4CEC-9D3E-6B2593B0D2B2 Q26801207-00F1EBA6-5751-406F-8D5C-72C9D096B7BF Q26801759-8D67F72D-5016-4BD1-887D-748444A97758 Q27333881-4DE0EDAD-DB44-46D7-BF9E-7CB86557198A Q27469019-7F7DBDD7-878B-4AA7-8664-3ED0A9E9CEFC Q27644406-C4136CD2-0BD7-4E64-A50F-D9C2851DD2F7 Q27684579-9916184B-F410-426A-BDAA-05D886348608 Q27693297-4BB3BFCD-8494-4ACE-AFD2-5AEF41934A47 Q28073406-87A7E94C-93A2-4A2F-B704-1E449348E73B Q28085146-64AF94B7-7FF8-49EC-9BC1-B40343CF218F Q28550514-0ABB7997-DDF4-4A21-9DA1-C0EF7B71DC1D Q28552909-129792B7-793B-40F0-B2D4-75395B339894 Q30364309-0F22E399-4EE6-4FA4-BCA6-54FD19FE62FF Q30374314-59BFA9CE-B00B-47E6-9515-B9FC1CC49F1F Q30383692-A0CBF1C1-4E44-4669-88C5-0476BB827559 Q30386551-09CF23AF-D2B0-4AA3-A4BA-794D1E60F2D6 Q33360674-D3A91E28-207C-470A-806A-D492E17F727D Q33612608-2AD5E621-8E40-4E1F-A5CB-DFA1CE80C418 Q33648339-6065B723-29BE-4DD9-8857-14CFABA7225C Q33691856-66656364-8F70-4230-8B15-1357AA1AC5A7 Q33739145-49B4720F-F586-4F4C-8A70-965E3B6398FA Q33759224-FB6970A9-FABA-41D1-AEC0-180A3D8032CD Q34262175-4BB2AAEE-4870-4466-B461-D97BED1AA314 Q34481429-3ACF3F2D-0655-4D6C-9999-4F4D253B93AA Q34594986-9ADF74A0-DBBA-405D-8C5B-2442FE9B6EE3 Q34792436-7F948723-C251-4D4D-802F-686779487BF2 Q34870033-87BF426F-FD6B-4345-A512-C1799F789DAB Q35450992-8F8F1BC5-F390-4EDC-9791-24D1B81EE8E9 Q35488198-C0EDEBAF-1CF7-4A1D-B8E9-FE135F83FADA Q35501190-F8632C36-E7F8-4F05-B667-671578678CE2 Q35619104-6459F7E7-419B-46AA-8D61-88C43F9355B0 Q35630492-A12443EF-7DB0-4B9B-9438-8F49059FAFE7 Q35739094-56BE4244-7111-4617-8D75-38856F5C0037 Q35787699-F15EA724-A8CE-4E38-A9F7-F0A4C60115A3 Q35872361-2E3AE21B-A396-43FE-93E0-AEEB8865274D Q35882278-F891BD60-6D99-4D4A-8E83-65F1FC031C1B Q35914270-23E455B7-1212-44A2-983F-AE46D0F912BC Q35942829-1235E4E0-8ABF-42CF-8D47-14EBC1F2521C

P2860

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

http://www.wikidata.org/entity/Q27681839

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@ast

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@en

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@nl

type

label

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@ast

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@en

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@nl

prefLabel

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@ast

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@en

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@nl

P1433

Q27681839-DC1FFADC-8F3E-4C83-A4AD-5F4DC30EBA96

P1476

Q27681839-CDDBEC71-002A-4909-AD1E-29DCC56E7138

P2093

Q27681839-1E6808DB-3A03-4995-92F5-E0D6DA06912A

Q27681839-20531C14-FC56-49FD-8221-AD4E3D7EE0EA

Q27681839-5257C869-810A-4F00-A4F4-BFC59B889B10

Q27681839-5648EDF3-1F01-4C0D-8794-D3562C267C41

Q27681839-6C0290A7-B8D1-4223-B7F4-FC558973E94A

Q27681839-6CB9AFC0-84DC-4FCA-8C4B-7DF0B3C10790

Q27681839-77776303-A79C-4A5F-9B7D-2D13F6700612

Q27681839-78F033B7-0F57-44A5-9BC5-EF89D7FC3922

Q27681839-876C7600-2960-4F8A-8E82-59D0BA13AC68

Q27681839-932B3D3A-A4E9-414A-86A5-A451D40D5B62

P2860

Q27681839-016439F1-3BF9-451B-AA34-2CC52D3BC27D

Q27681839-0E67D025-964C-4817-AC15-4A3477511E0D

Q27681839-13A0E8C5-1999-411A-AC94-CDF3ABF503BC

Q27681839-1A4DEB77-F9A9-4F90-A1BE-7071E605A827

Q27681839-236B1C6D-98DC-4D62-B72A-EDEBD3444BCD

Q27681839-2990D96A-EDA4-495F-9624-B1236AE1EB6E

Q27681839-2F5C1161-827E-45E5-BA5A-BB1AF0BFC545

Q27681839-3884FC07-A5AE-442C-B0DF-8EF879E1589A

Q27681839-4A397EF1-6028-4E6B-8363-066C1A0148C9

Q27681839-530FBBCB-F2C4-4E58-82EE-5DA7B06D9929

P2888

Q27681839-F248F69C-59B8-4B56-8EB0-2FEDE8A58ABC

P304

Q27681839-6BC51416-E330-4EAB-AE9B-B87FD19767A4

P31

Q27681839-ECD0F2CA-C1BE-4E89-BA12-635990AD2AF8

P3181

Q27681839-A9F2670A-514A-4734-AD33-C9411C32B746

P356

Q27681839-C7787DF1-81A8-4DB9-A431-2C719769AAA2

P407

Q27681839-8C8B394D-B6AB-4D81-81D9-BC4E1BD25E93

P433

Q27681839-2214D337-6E79-4203-AAB3-07F5B751EFF6

P478

Q27681839-C9DC1E72-1986-48DD-A53A-BB378FDB2BB3

P50

Q27681839-69B706A2-6369-470A-8E6D-162D6EE68AA0

P577

Q27681839-AAAA287F-B41A-4A9F-9E9A-C77B4F2D4A0B

P5875

Q27681839-42320323-9F27-45BD-8043-057B991EFF35

P6179

Q27681839-9D9A7F44-1410-4D1C-9D32-C3E6DBAD7F40

P698

Q27681839-B5320D58-9D86-43A1-B6AC-9F758C5E2B53

P932

Q27681839-32562810-6EE2-4B1F-8B32-D1B0E638E477

P3181

P356

P1433

P1476

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

@en

P2093

Abdul Ghafoor Khan

http://www.w3.org/2001/XMLSchema#string

Alexandra V Zatorski

http://www.w3.org/2001/XMLSchema#string

Alicja Cygan

http://www.w3.org/2001/XMLSchema#string

Arash Grakoui

http://www.w3.org/2001/XMLSchema#string

Aryn A Price

http://www.w3.org/2001/XMLSchema#string

Caitlin D Bohannon

http://www.w3.org/2001/XMLSchema#string

Hannah Scarborough

http://www.w3.org/2001/XMLSchema#string

Jillian Whidby

http://www.w3.org/2001/XMLSchema#string

Joseph Marcotrigiano

http://www.w3.org/2001/XMLSchema#string

Joshy Jacob

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing

MAFFT version 5: improvement in accuracy of multiple sequence alignment

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Jalview Version 2--a multiple sequence alignment editor and analysis workbench

Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding

Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death

P2888

P304

381-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1296240

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE13117

http://www.w3.org/2001/XMLSchema#string

P407

P433

7500

http://www.w3.org/2001/XMLSchema#string

P478

509

http://www.w3.org/2001/XMLSchema#string

P50

Samantha A Yost

P577

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260270969

http://www.w3.org/2001/XMLSchema#string

P6179

1006344484

http://www.w3.org/2001/XMLSchema#string

P698

24553139

http://www.w3.org/2001/XMLSchema#string

P932

4126800

http://www.w3.org/2001/XMLSchema#string